XRTX Annual CFI
-$46.40 K
-$2200.00-4.98%
01 December 2023
Summary:
As of January 23, 2025, XRTX annual cash flow from investing activities is -$46.40 thousand, with the most recent change of -$2200.00 (-4.98%) on December 1, 2023. During the last 3 years, it has fallen by -$35.10 thousand (-310.62%). XRTX annual CFI is now -3966.67% below its all-time high of $1200.00, reached on February 1, 2017.XRTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XRTX Quarterly CFI
-$23.20 K
-$14.10 K-154.95%
01 September 2024
Summary:
As of January 23, 2025, XRTX quarterly cash flow from investing activities is -$23.20 thousand, with the most recent change of -$14.10 thousand (-154.95%) on September 1, 2024. Over the past year, it has dropped by -$13.40 thousand (-136.73%). XRTX quarterly CFI is now -573.47% below its all-time high of $4900.00, reached on November 1, 2016.XRTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XRTX TTM CFI
-$44.70 K
-$15.90 K-55.21%
01 September 2024
Summary:
As of January 23, 2025, XRTX TTM cash flow from investing activities is -$44.70 thousand, with the most recent change of -$15.90 thousand (-55.21%) on September 1, 2024. Over the past year, it has increased by +$1600.00 (+3.46%). XRTX TTM CFI is now -927.78% below its all-time high of $5400.00, reached on November 1, 2016.XRTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XRTX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.0% | -136.7% | +3.5% |
| 3 y3 years | -310.6% | -17.8% | +28.8% |
| 5 y5 years | +59.2% | -17.8% | +28.8% |
XRTX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -48.7% | at low | -792.3% | at low | -55.2% | +28.8% |
| 5 y | 5-year | -759.3% | at low | <-9999.0% | at low | -727.8% | +28.8% |
| alltime | all time | -3966.7% | +67.5% | -573.5% | +78.9% | -927.8% | +61.7% |
XORTX Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$23.20 K(+154.9%) | -$44.70 K(+55.2%) |
| June 2024 | - | -$9100.00(+250.0%) | -$28.80 K(-1.4%) |
| Mar 2024 | - | -$2600.00(-73.5%) | -$29.20 K(-36.9%) |
| Dec 2023 | -$46.40 K(+5.0%) | -$9800.00(+34.2%) | -$46.30 K(-13.1%) |
| Sept 2023 | - | -$7300.00(-23.2%) | -$53.30 K(+5.1%) |
| June 2023 | - | -$9500.00(-51.8%) | -$50.70 K(-19.3%) |
| Mar 2023 | - | -$19.70 K(+17.3%) | -$62.80 K(+37.4%) |
| Dec 2022 | -$44.20 K(+41.7%) | -$16.80 K(+257.4%) | -$45.70 K(+6.8%) |
| Sept 2022 | - | -$4700.00(-78.2%) | -$42.80 K(-9.9%) |
| June 2022 | - | -$21.60 K(+730.8%) | -$47.50 K(+38.9%) |
| Mar 2022 | - | -$2600.00(-81.3%) | -$34.20 K(+7.9%) |
| Dec 2021 | -$31.20 K(+176.1%) | - | - |
| Dec 2021 | - | -$13.90 K(+47.9%) | -$31.70 K(+54.6%) |
| Sept 2021 | - | -$9400.00(+13.3%) | -$20.50 K(+39.5%) |
| June 2021 | - | -$8300.00(+8200.0%) | -$14.70 K(+61.5%) |
| Mar 2021 | - | -$100.00(-96.3%) | -$9100.00(-19.5%) |
| Dec 2020 | -$11.30 K(+109.3%) | -$2700.00(-25.0%) | -$11.30 K(+28.4%) |
| Sept 2020 | - | -$3600.00(+33.3%) | -$8800.00(+10.0%) |
| June 2020 | - | -$2700.00(+17.4%) | -$8000.00(+3.9%) |
| Mar 2020 | - | -$2300.00(+1050.0%) | -$7700.00(+42.6%) |
| Dec 2019 | -$5400.00 | -$200.00(-92.9%) | -$5400.00(+157.1%) |
| Sept 2019 | - | -$2800.00(+16.7%) | -$2100.00(-74.1%) |
| June 2019 | - | -$2400.00(<-9900.0%) | -$8100.00(+118.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $0.00(-100.0%) | -$3700.00(-96.7%) |
| Dec 2018 | -$113.70 K(-20.4%) | $3100.00(-135.2%) | -$113.60 K(-2.7%) |
| Sept 2018 | - | -$8800.00(-540.0%) | -$116.70 K(+8.2%) |
| June 2018 | - | $2000.00(-101.8%) | -$107.90 K(-1.8%) |
| Mar 2018 | - | -$109.90 K(<-9900.0%) | -$109.90 K(+2580.5%) |
| Dec 2017 | -$142.90 K(<-9900.0%) | - | - |
| Nov 2017 | - | $0.00(0.0%) | -$4100.00(-612.5%) |
| Aug 2017 | - | $0.00(0.0%) | $800.00(0.0%) |
| May 2017 | - | $0.00(-100.0%) | $800.00(0.0%) |
| Mar 2017 | - | -$400.00(-89.2%) | $800.00(-33.3%) |
| Feb 2017 | $1200.00(-106.6%) | -$3700.00(-175.5%) | $1200.00(-77.8%) |
| Dec 2016 | -$18.30 K(-53.2%) | - | - |
| Nov 2016 | - | $4900.00(>+9900.0%) | $5400.00(-115.8%) |
| Aug 2016 | - | $0.00(0.0%) | -$34.20 K(-9.8%) |
| May 2016 | - | $0.00(-100.0%) | -$37.90 K(-3.1%) |
| Feb 2016 | -$39.10 K(+62.2%) | $500.00(-101.4%) | -$39.10 K(+0.5%) |
| Nov 2015 | - | -$34.70 K(+837.8%) | -$38.90 K(+1241.4%) |
| Aug 2015 | - | -$3700.00(+208.3%) | -$2900.00(-23.7%) |
| May 2015 | - | -$1200.00(-271.4%) | -$3800.00(-84.3%) |
| Feb 2015 | -$24.10 K | $700.00(-46.2%) | -$24.20 K(-2.8%) |
| Nov 2014 | - | $1300.00(-128.3%) | -$24.90 K(-5.0%) |
| Aug 2014 | - | -$4600.00(-78.7%) | -$26.20 K(+21.3%) |
| May 2014 | - | -$21.60 K | -$21.60 K |
FAQ
- What is XORTX Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for XORTX Therapeutics?
- What is XORTX Therapeutics annual CFI year-on-year change?
- What is XORTX Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly CFI year-on-year change?
- What is XORTX Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for XORTX Therapeutics?
- What is XORTX Therapeutics TTM CFI year-on-year change?
What is XORTX Therapeutics annual cash flow from investing activities?
The current annual CFI of XRTX is -$46.40 K
What is the all time high annual CFI for XORTX Therapeutics?
XORTX Therapeutics all-time high annual cash flow from investing activities is $1200.00
What is XORTX Therapeutics annual CFI year-on-year change?
Over the past year, XRTX annual cash flow from investing activities has changed by -$2200.00 (-4.98%)
What is XORTX Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of XRTX is -$23.20 K
What is the all time high quarterly CFI for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly cash flow from investing activities is $4900.00
What is XORTX Therapeutics quarterly CFI year-on-year change?
Over the past year, XRTX quarterly cash flow from investing activities has changed by -$13.40 K (-136.73%)
What is XORTX Therapeutics TTM cash flow from investing activities?
The current TTM CFI of XRTX is -$44.70 K
What is the all time high TTM CFI for XORTX Therapeutics?
XORTX Therapeutics all-time high TTM cash flow from investing activities is $5400.00
What is XORTX Therapeutics TTM CFI year-on-year change?
Over the past year, XRTX TTM cash flow from investing activities has changed by +$1600.00 (+3.46%)